DI
CORT icon

Disciplined Investments’s Corcept Therapeutics CORT Stock Holding History

Disciplined Investments’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17
Closed -$378 – 408
2023
Q2 		$378 Buy
17
+1
+6% +$23 ﹤0.01% 1331
2023
Q1 		$347 Buy
16
+5
+45% +$110 ﹤0.01% 1349
2022
Q4 		$223 Sell
11
-9
-45% -$226 ﹤0.01% 1416
2022
Q3 		$1K Sell
20
-1
-5% -$27 ﹤0.01% 844
2022
Q2 		$0 Buy
21
+4
+24% +$87 ﹤0.01% 1318
2022
Q1 		$0 Buy
+17
New +$362 ﹤0.01% 1383

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Disciplined Investments's CORT Position: Q3 2023 in Review

Disciplined Investments sold out of Corcept Therapeutics (CORT) in Q3 2023, closing a stake of 17 shares — an estimated $378 sold.

Disciplined Investments first reported a position in CORT in Q1 2022 and held it in 6 quarters. The position peaked at $1K in Q3 2022. 246 funds tracked by Wall St. Rank hold CORT as of Q3 2023.

  • Disciplined Investments reported no remaining Corcept Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 17 Corcept Therapeutics shares in Q3 2023, an estimated $378.
  • Disciplined Investments first reported a position in Corcept Therapeutics in Q1 2022 and held it in 6 quarters.
  • Disciplined Investments's Corcept Therapeutics position peaked at $1K in Q3 2022.
  • 246 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.